Cytokine profile and disease severity in patients with COVID-19
COVID-19 환자의 사이토카인 프로필 및 질병 중증도
Article
[키워드] (enzyme-linked immunosorbent assay
age
All participants
Analysis
ANOVA
both groups
can be used
collected
Concentration
conducted
control group
controls
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
COVID-19 patient
COVID-19 patients
cytokine
Cytokine dysregulation
cytokine level
cytokine levels
Cytokines
disease severity
dysregulation
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
evaluate
healthy subject
IFN-γ
IL-17
IL-5
IL-8
IL-9
in both group
infected with SARS-CoV-2
interferon
interferon-γ
interleukin
involved
mechanism
Mild
not differ
one-way ANOVA
participant
Patient
patients
patients with COVID-19
Predictive
proinflammatory
responses
serum
Serum level
serum levels
serum sample
serum samples
severe group
severity
significant difference
significant differences
significantly
significantly higher
statistical analysis
systemic
tested
TGF-β
Th1
Th17
Treg
was performed
[DOI] 10.1016/j.cyto.2020.155323 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.cyto.2020.155323 PMC 바로가기 [Article Type] Article